Cusatuzumab Uses, Dosage, Side Effects and more
Cusatuzumab is under investigation in clinical trial NCT01813539 (Phase 1/2 Study of ARGX-110 in Patients With Advanced Malignancies).
| Trade Name | Cusatuzumab |
| Generic | Cusatuzumab |
| Cusatuzumab Other Names | Cusatuzumab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
